NZ First has released a list of campaign commitments, including its health policies, for next month’s general election, but none of them have been costed
A seven year battle on behalf of hundreds of people living with the most debilitating form of Multiple Sclerosis has been won – with Pharmac agreeing to fund Aotearoa New Zealand’s first ever treatment for the disease variant from October 1st
People with haemophilia A and multiple sclerosis are set to benefit from a multi-medicine funding agreement between Pharmac and Roche Products (NZ), confirmed today
Te Pātaka Whaioranga – Pharmac has confirmed it is widening access to emicizumab (branded as Hemlibra) for the treatment of people with severe haemophilia A without factor VIII inhibitors
Te Pātaka Whaioranga – Pharmac has confirmed it is widening access to ocrelizumab (branded as Ocrevus) as the first funded treatment for primary progressive multiple sclerosis
The RNZCGP accused accused the National Party of “political gamesmanship” over its plan to slash the number of people receiving free prescriptions to fund new cancer drugs
Te Pātaka Whaioranga - Pharmac is taking steps to ensure people with type 2 diabetes who take dulaglutide (branded as Trulicity) can continue to access the treatment while we experience further supply chain issues on top of a global shortage
Te Pātaka Whaioranga - Pharmac is seeking bids from suppliers for two medicines, lenalidomide and pomalidomide, for use in the treatment of multiple myeloma
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management